- Report
- October 2023
- 159 Pages
Global
From €4275EUR$4,500USD£3,678GBP
- Report
- September 2023
- 449 Pages
Global
From €4703EUR$4,950USD£4,045GBP
- Report
- January 2024
- 200 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- December 2023
- 200 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- February 2024
- 175 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- January 2024
- 175 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- January 2024
- 175 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- November 2023
- 146 Pages
Global
From €2374EUR$2,499USD£2,042GBP
- Report
- November 2023
- 190 Pages
Global
From €4655EUR$4,900USD£4,005GBP
- Report
- November 2023
- 181 Pages
Global
From €4655EUR$4,900USD£4,005GBP
- Report
- February 2024
- 110 Pages
Global
From €4513EUR$4,750USD£3,882GBP
- Report
- February 2024
- 114 Pages
Global
From €4038EUR$4,250USD£3,473GBP
- Report
- January 2024
- 145 Pages
Global
From €4038EUR$4,250USD£3,473GBP
- Report
- September 2023
- 143 Pages
Global
From €4228EUR$4,450USD£3,637GBP
- Report
- March 2024
- 200 Pages
Global
From €3943EUR$4,150USD£3,392GBP
- Report
- October 2023
- 97 Pages
Global
From €2803EUR$2,950USD£2,411GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4703EUR$4,950USD£4,045GBP
- Report
- January 2022
- 191 Pages
Global
From €4038EUR$4,250USD£3,473GBP
- Report
- October 2020
- 60 Pages
Global
From €938EUR$988USD£807GBP
€1876EUR$1,975USD£1,614GBP
- Report
- January 2023
- 95 Pages
Global
From €2366EUR$2,490USD£2,035GBP
The Lung Disease market within the context of Pulmonary Medicine is a highly specialized field of medicine that focuses on the diagnosis and treatment of diseases and disorders of the lungs. This includes conditions such as asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease, pulmonary hypertension, and lung cancer. Pulmonologists are the primary healthcare providers for these conditions, and they work closely with other specialists such as allergists, oncologists, and radiologists to provide comprehensive care.
The Lung Disease market is a rapidly growing field, with new treatments and technologies being developed to improve patient outcomes. In addition, the increasing prevalence of smoking and air pollution has led to an increase in the number of people suffering from lung diseases.
Some of the major companies in the Lung Disease market include AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. These companies are involved in the development and marketing of drugs, devices, and diagnostics for the treatment of lung diseases. Show Less Read more